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Chapter 1. Introduction 
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1-1. General introduction 
 
Components of skeletal muscle 
Skeletal muscle has the following functions such as movement, stability, and heat 
production. Skeletal muscle is composed by muscular tissues and fibrous connective 
tissues. Muscle tissue is made up with muscle fibers. Fibrous connective tissues include 
blood vessels and nerve fiber which are covered with the epimysium, perimysium, and 
endomysium (Figure 1-1). Muscle fibers are surrounded by the sarcolemma (Figure 1-2). 
The sarcolemma surrounds both sarcoplasm and muscle fibers. The sarcoplasm in the 
sarcolemma has the sarcoplasmic reticulum and T-tubule which are involved in the rise 
of action potential (Figure 1-3). Muscle fiber has multiple nuclei and is made up by 
nascent single nucleus muscle cell called myoblast. When myoblasts are fused, muscle 
fiber is formed. Satellite cells are muscle stem cells which is located between the 
muscle fiber and sarcolemma. If the muscle is damaged, they can supply new muscle 
fibers. 
Each muscle fiber consists of myofibrils. The unit of myofibril is called 
sarcomere (Figure 1-4). There are thin filaments (actin) and thick filaments (myosin) in 
the sarcomere. The thin filament consists of actin, tropomyosin, and troponin. The thick 
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filament is made up of the myosin protein. Myosin has two heads which are twisted in 
the thick filament and located toward the thin filament. They can bind to actin in the 
thin filament. When myosin heads combine to actin, myofibril is contracted and force is 
generated. 
 
Relationships of skeletal muscle and nerve 
Skeletal muscle contracts when it is stimulated by somatic nervous system. If the 
somatic nervous systems cannot transmit signal to skeletal muscles, muscles are 
paralyzed. Therefore, in order to understand skeletal muscle contractions, the 
knowledge of relationship between muscle and nerve systems is needed. Skeletal 
muscles are regulated by motor neurons in the nervous system. Cell bodies of the motor 
neurons are located in the brain and spinal cord. They are called somatic motor nerve 
fibers and control the skeletal muscle. Somatic motor nerve fiber innervates more than 
two muscle fibers. The unit of nerve fiber and muscle fibers are called motor unit. It is 
important for controlling movement and strength exertion of the skeletal muscle. The 
spot where a nerve fiber connects to the muscle fiber is called the neuromuscular 
junction. When a signal of the nerve fiber reaches the neuromuscular junction, it 
stimulates the skeletal muscle fibers. As a result, skeletal muscles are contracted (Figure 
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1-5). 
The stage of the muscle contraction can be explained by the following four major 
phases; 1) Excitation, 2) Excitation-contraction coupling, 3) Contraction, and 4) 
Relaxation. When action potential in the nerve fiber arrives to the end of motor neuron, 
acetylcholine is released. Released acetylcholine combines to the receptors on the motor 
end plates. As a result, action potentials in the nerve fiber elicit action potentials in the 
muscle fiber. This stage is called 1) Excitation (Figure 1-5, ①). Action potential in 
muscle fiber is transmitted to T-tubule. Sarcoplasmic reticulum releases calcium ions 
and then combines with the troponin of the thin filaments. This link is called  2) 
Excitation-contraction coupling (Figure 1-5, ②~③). 3) Contraction is a stage where 
muscle fiber creates tension and is shortened. This stage is where tropomyosin shifts 
and expose myosin binding site. As a result, thin filaments (myosin) pulls in thick 
filaments (actin). Sarcomere is shortened and muscle fiber is contracted (Figure 1-5, 
④). When the signal of the nerve fiber cannot transmit to the neuromuscular junction, 
contraction is finished and muscle fiber returns to its original length. This stage is called 
4) Relaxation (Figure 1-5, ⑤~⑦). 
 
 
10 
 
The nervous system and consisting cells 
The nervous systems can be practically divided into central nervous system 
(CNS) and peripheral nervous system (PNS). CNS consists of the brain and the spinal 
cord. PNS includes the nerves and ganglia except CNS. PNS connect CNS to the target 
tissues/organs. PNS is divided into the somatic nervous system, the sensory nervous 
system, and the autonomic nervous system. From the three nervous systems mentioned 
above, the somatic nervous system is associated with the voluntary control of the body 
movements via skeletal muscles. 
Nervous tissue is composed of nerve cells and glial cells. Nerve cell transmits 
information electrically and chemically. Nerve cell is frequently called neuron. Glial 
cell directly contacts with the nerve cells and often surround them. Neuron basically 
consists of cell body, axon, and many dendrites. Dendrites receive information from 
another cell and transmit the message to the cell body. The cell body contains the 
nucleus, mitochondria and other cell organelles. The signals from the cell body are 
transmitted by the axon. Nerve cells are divided into three types. First is the sensory 
neuron which has a long dendrite and short axon. It carries signals to the CNS. Second 
is the motor neuron which has a long axon and short dendrites and transmits signals to 
the muscles. Third is the interneuron which transmits neuron to neuron in the CNS. 
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On the other hand, glial cells serve as a supportive role in neural tissue. In PNS, 
most axons are surrounded by the myelin sheath. The specialized glial cell called the 
Schwann cell is  supportive and nutritive to the neuron [1] (Figure 1-6).  
 
Types of skeletal muscle injury 
Skeletal muscle injuries are caused by physical exercise when skeletal muscle is 
overused and/or over stretched. Main muscle injuries caused by body movement are 
muscle soreness and muscle strain. Muscle soreness accompanies pain and is divided 
into acute muscle soreness and delayed onset muscle soreness. Acute muscle soreness 
is one form of exercise-induced muscle damage. Although acute muscle soreness 
occurs immediately after exercise and continues to pain for several minutes, pain of 
delayed onset muscle soreness appears between 24 hours and 72 hours after exercise. 
The causes are accumulation of chemicals, edema, and muscle fatigue.  
Muscle strain is tears of muscle fibers and damages which occur in both muscle 
and tendon. Tendon is fibrous tissues and connects muscle and bone. Muscle strain is 
caused by overuse of muscle and tendon and also as a result of overstretching and/or 
excessive muscle contraction during exercise like eccentric contraction. The main part 
where the strain occurs is the hamstrings. Strain accompanies pain, swelling, 
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inflammation, and weakness. More severe strain experiences loss of muscle function. 
Strains are divided into three grades (Table 1-1). First grade is the mild strain. Some 
muscle fiber is damaged and can be recovered within two weeks. Second grade is also 
damaged muscle fibers. Recovery is accomplished by more than four weeks. Third 
grade is a severe injury with ruptured muscle fibers. About six month periods are 
required for recovery. 
 
Types of peripheral nerve injury 
As depicted above, nerve tissues consist of neural cells and glial cells. In PNS, 
Schwann cells make myelin sheath and surround nerve cell axon (Figure 6). When 
peripheral nerve injury occurs, axon and/or myelin sheath might be damaged. According 
to the Seddon’s classifications [2] (Figure 1-7), peripheral nerve injury is divided into 
three types, such as neurapraxia, axonotmesis and neurotmesis. Neurapraxia is 
temporary damage to the myelin sheath but the nerve cell axon and Schwann cell 
remains intact. Since it is an impermanent injury, the myelin damage can be repaired. 
Axonotmesis is a damage of the nerve cell axon. Compared with neuropraxia, both 
myelin sheath and axon are damaged. Because the Schwann cell remains intact, 
damaged myelin sheath and axon can be regenerated. By a more severe crush or 
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contusion, the nerve tissue is damaged. Neurotmesis is an entire disruption or damage of 
the nerve fiber. It is the most critical nerve injury and means the severance of the nerve 
fiber. Unlike the CNS, regeneration is possible in the PNS, and, in that case, Schwann 
cell plays an important role in damaged peripheral nerve regeneration [3-5]. 
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1-2. Mechanism of the skeletal muscle protein degradation after 
eccentric contractions 
 
Eccentric contractions cause a skeletal muscle injury 
Skeletal muscle contractions are divided into the following three types, isometric 
contraction, concentric contraction and eccentric contraction. Isometric contraction is a 
muscle contraction without change in the muscle length. Because isometric contraction 
is maintained in astatic position, a range of motion does not change. However, muscle 
length shortens when muscle is concentrically contracted. Eccentric contraction (EC) is 
the opposite of concentric. 
Since exerting force of eccentric contraction is the largest among three types of 
muscle contractions, the diverse effects of eccentric contractions have been reported 
[6-8]. Because the contracting muscle is forcibly lengthened during ECs, more and 
more sarcomeres will become overstretched [9], beginning with the weakest and 
progressively including stronger sarcomeres. Moreover, when ECs are repeated, more 
and more sarcomeres become disrupted. Disrupted sarcomeres lead to structural 
distortions and membrane damage of sarcoplasmic reticulum, transverse tubules, or the 
sarcolemma [6]. This is accompanied by the uncontrolled release of Ca
2+ 
and 
15 
 
dysfunction of the excitation-contraction (E-C) coupling system, triggering the damage 
process [10-12]. If the damage was extensive enough, muscle fibers would die and lead 
to local inflammatory response associated with tissue edema and soreness [13]. 
Generally, this muscle damage is characterized by sustained loss of muscle force and 
range of motion, histologic disturbance of muscle and connective tissue, large decreases 
of muscle proteins and oxidative stress in the blood, shift in optimum length, fall in 
active tension, rise in passive tension and development of delayed-onset muscle 
soreness (DOMS) and swelling [6, 11, 14-16]. 
Among the injuries by ECs, muscle strain injury is not the result of muscle 
contraction alone, rather, strains are the result of excessive stretch while the muscle is 
being activated [17]. ECs impose a greater amount of tension on the active muscle. In 
particular, high-speed ECs seem to exert an additional effect on muscle tension. Thus, 
ECs induces both muscle hypertrophy and muscle damages [8, 18-21]. Furthermore, 
severe ECs with larger range of motion and/or faster contraction velocity tend to induce 
severe muscle damage [7, 22, 23]. In fact, Song [24] and Ochi et al. [25] showed that 
ECs with a larger range of motion and/or faster angular velocity cause functional and 
histological damage to the rat gastrocnemius muscle. For this reasons, severe ECs have 
been considered to induce muscle strain injury. 
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The mechanism of the skeletal muscle degradation 
In previous study, Ochi et al. [25] have reported that severe ECs induce 
skeletal-muscle protein degradation. Muscle atrophy occurs when there is an imbalance 
between protein degradation and synthesis. Skeletal muscle atrophy happens when 
muscle protein degradation exceeds synthesis [26]. It has been reported that there are 
four mechanisms in protein degradation [27] (Figure 1-8). The first mechanism is the 
ubiquitin-proteasome system. The second is the autophagy-lysosome system. The third 
is the calpain system. The fourth is the caspase system. It has been reported that the 
ubiquitin-proteasome system is the major cause to skeletal muscle atrophy [28]. The 
ubiquitin-proteasome system induces protein degradation by up-regulation of two 
ubiquitin-protein ligase, muscle-specific ubiquitin ligases muscle atrophy F-box 
(MAFbx, another name is an atrogin-1) and muscle RING finger 1 (MuRF1) [29, 30]. 
Furthermore, the expression of MAFbx is regulated by forkhead box O (FoxO) of 
transcription factor [31]. 
When the inactivated FoxOs located in the cytoplasm becomes dephosphorylated, it 
moves to the nucleus for transcription of MAFbx and MuRF1. (Figure 1-9). Moreover, 
the expression of FoxOs results from decreased activation of Akt/mammalian target of 
rapamycin (mTOR)/p70s6k signaling pathway which activates protein synthesis making 
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it to an anabolic states [32, 33]. The Akt signaling pathway is a positive regulator of 
muscle protein synthesis and muscle hypertrophy [34, 35]. As a result, phosphorylated 
FoxOs suppress protein degradation and promote protein synthesis [32]. On the contrary, 
the expression of FoxOs in the nucleus stimulates protein degradations. 
   Another regulator of MAFbx and MuRF1 is the myostatin [36, 37]. Myostatin 
belongs to the member of transforming growth factor (TGF)-beta superfamily [38] and 
is a negative regulator of muscle hypertrophy [39]. Mutation of myostatin has been 
reported to result in growth of muscle mass [40]. In addition, myostatin has been 
reported to inhibit myoblast differentiation and myotube growth [41] and regulates 
FoxO1- dependent mechanism [36] (Figure 1-9). Moreover, the expression of myostatin 
stimulates protein degradation and suppresses protein synthesis [41, 42]. In previous 
study, Ochi et al. have reported that ECs with 180°/s angular velocities induce higher 
expression levels of FoxO1, FoxO3a and myostatin [25]. Furthermore, they observed 
that ECs with slower angular velocity (30°/s) did not induce the expression of FoxO 
proteins. Because these proteins lead to degradation of muscle proteins, 180°/s ECs 
might induce muscle atrophy. However, the mechanism of inducing muscle protein 
degradation by ECs has not been elucidated. 
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The possibility of skeletal muscle degradation following AMPK activation after 
eccentric contractions 
5′-AMP-activated protein kinase (AMPK), a well-characterized sensor of cellular 
energy state [43-45], consists of three subunits, namely, a single catalytic domain (α) 
and two regulatory domains (β and ). Phosphorylation of the α-subunit is required for 
AMPK activation, which initiates transcriptional and metabolic events that generate 
AMP and inhibit ATP-consuming processes. In skeletal muscle, AMPK is activated by a 
variety of ATP-consuming stimuli, such as exercise [46], electrical stimulation [47] and 
glucose deprivation [48]. 
Recent reports have suggested that AMPK activation inhibits myoblast 
differentiation, protein synthesis, and hypertrophy in skeletal muscle [49-54]. Treatment 
with the AMPK activator, 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), 
has been shown to stimulate expression of the MAFbx and MuRF1 [51]. Moreover, 
AMPK activation by AICAR treatment is known to inhibit contraction-induced 
activation of mTOR [52] and hypertrophy [49] in rat skeletal muscles. Furthermore, the 
activation of AMPK in C2C12 cells has been shown to reduce myotube formation [50], 
induce degradation of myofibrillar protein, and stimulate expression of the transcription 
factors MAFbx and FoxO [54]. In addition, skeletal muscle hypertrophy in AMPKα1 
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knockout mice suggests that AMPK plays an important role in limiting muscle growth 
[53]. 
Ochi et al. have recently shown that eccentric contractions (ECs) induce 
expression of the atrophy-related factors FoxO1, FoxO3a, and myostatin in rat’s 
gastrocnemius muscle [25]. Although the molecular mechanisms underlying these 
events are uncertain, as described above, FoxO transcriptional factors and other 
atrophy-related factors have been shown to be induced by activation of AMPK. 
Furthermore, binding assays have demonstrated the presence of functional binding sites 
for FoxO1 and SMADs in the myostatin promoter [55]. These lines of evidence suggest 
that induction of the expression and activity of FoxO transcriptional factors in response 
to AMPK activation stimulates myostatin levels, resulting in muscle atrophy. 
Therefore, in chapter 2, I hypothesized that AMPK plays a key role in regulating 
the expression of atrophy-related factors in rat gastrocnemius in response to ECs with 
severe ankle joint torque deficit. 
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1-3 Skeletal muscle and peripheral nerve damages following eccentric 
contractions 
 
Relationships between eccentric contractions and a peripheral nerve injury 
Although muscles are composed of various tissues, including muscle fibers, blood 
vessels, and nerves, research on muscle injury has generally focused on damage only to 
muscle tissues. However, muscle damage induced by ECs has reportedly produced 
alterations in peripheral nerve function such as changes in excitation-contraction (E-C) 
coupling and in motor unit recruitment [12, 56-58]. With regard to muscle injury, Kami 
et al. [59] showed that muscle contusion injuries cause not only muscle damage but also 
injury to nerve cells. They found up-regulation of neurotrophic factors and their 
receptors in motor neurons and Schwann-like cells in damaged muscle, similar to those 
found after nerve transection. This suggested that inflammatory reactions in damaged 
non-neuronal tissues might facilitate nerve damage. Similarly, overstretching, disruption, 
and inflammation of muscle fibers by ECs may damage nerve cells. This phenomenon 
has not been examined previously. Furthermore, since nerve damage leads to the 
reduction of muscle strength and muscle atrophy, there is a possibility that nerve 
damages occur especially in severe muscle damages.  
21 
 
Roles of schwann cell, macrophages and neurotrophins under nerve injury and 
repair 
Nerve tissues consist of neural cells and glial cells. In the PNS, Schwann cell is 
one of the glia cells. They make myelin sheath and surround nerve cell axon. Unlike in 
the CNS, regeneration in the PNS is possible. When peripheral nerve injury occurs, 
axons and/or myelin sheaths are damaged [1, 60]. Schwann cells play an important role 
in regeneration of damaged peripheral nerves [3-5]. During PNS development and 
regeneration, Schwann cells ensheath individual axons and eventually form the myelin 
sheath [1]. Schwann cell migration is essential for responses to tissue damage after 
injury [61]. At the same time, macrophages infiltrate in order to remove debris, 
specifically myelin and damaged axons, from the injury site [5, 62, 63]. Macrophages 
do not phagocytose all cellular debris at the nerve injury site [64] but rather select and 
salvage damaged myelin and axons [60, 65, 66]. In addition to Schwann cells, 
neurotrophins play multiple roles in the development of the peripheral nervous system, 
and they contribute to Schwann cell survival, growth, and differentiation [3, 61, 67, 68]. 
Neurotrophins include nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5). They are activated by 
the tropomyosin-receptor-kinases (Trks). NT-3 activation of TrkC induces Schwann cell 
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migration through the c-jun N-terminal kinase pathway [61]. After peripheral nerve 
injury, neurotrophic factors are upregulated and contribute to successful regeneration 
[69, 70]. 
 
Measure of nerve conduction velocity 
Nerve conduction velocity (NCV) is one of the measurement methods that is used 
to diagnose neuromuscular diseases and damage [71, 72]. As mentioned above, muscle 
damage that is induced by ECs has reportedly produced functional alterations in muscle 
spindle and motor units [12, 56-58]. The overstretching, disruption, and inflammation of 
muscle fibers by ECs may possibly damage nerve tissue. The measurement of NCV is 
an available method for determining functional nerve damage following ECs. Therefore, 
in order to confirm nerve damage, it is important to examine whether NCV is changed 
after ECs. As with NCV, assessments of these various factors and pathways can be used 
to measure peripheral nerve damage. Although it has been reported that exercise 
training improves NCV after sciatic nerve crush [73, 74], no studies have examined 
whether ECs affect NCV. The hypothesis of chapter3 is that excessive ECs causing 
muscle protein degradation induces structural damage and functional deficits of the 
sciatic nerve and its branches.
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1-4 Causes of the skeletal muscle atrophy by nerve damage 
 
Skeletal muscle atrophy is dependent on muscle fiber type in nerve damage  
Skeletal muscle atrophy is a result of disuse, aging, and diseases. Many researchers 
have reported about the mechanism of skeletal muscle atrophy. In general, experiments 
about the mechanism of skeletal muscle atrophy have been conducted using an 
immobilization and denervation model. In addition, the fashion of skeletal muscle 
atrophy seems to be dependent on muscle fiber type. Muscle fiber types are categorized 
into two main types due to metabolic activity. The first type is slow-twitch fibers (type1) 
and the other type is fast twitch fibers (type2). Slow-twitch fibers and fast twitch fibers 
are called oxidative muscle fibers and glycolytic muscle fibers, respectively. Moreover, 
fast twitch fibers can be divided into two types: type2A and type2B. Although the 
mechanism of fiber-specific muscle atrophy is unclear, it has been reported that 
immobilization induces skeletal muscle atrophy due to disuse and mainly decreasing 
muscle fibers which are slow-twitch fibers. On the other hand, the atrophy of fast-twitch 
fibers is attributed to denervation which in result causes loss of motor neuron. The 
molecular mechanism and phenomenon about muscle atrophy using inactivity and 
denervation model have been reported. However, the mechanism of muscle atrophy 
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following nerve damage remains poorly understood. 
 
Relationship between nerve crush injury and muscle damage 
Nerve injury has been reported to be the cause of skeletal muscle atrophy [75]. 
Especially, the denervation of skeletal muscle has been researched to investigate the 
mechanism of muscle atrophy. Although many studies observed that the denervation 
triggers expression of atrophy-related factors (MAFbx, MuRF1, FoxO1, FoxO3a, and 
myostatin), molecular mechanisms of denervation have not been well understood. 
Moreover, Nerve crush injury (NCI) is one type of the nerve damage and NCI is similar 
to neuropraxia or axonotmesis according to the Seddon’s classifications (Figure 1-7). 
However, the molecular mechanism of the NCI has not been sufficiently elucidated. 
Although one group reported that NCI induces the expression of myostatin, why 
myostatin increases is not yet known. In chapter 2 and 3, I observed that AMPK 
activated by ECs stimulate the expression of FoxO1, FoxO3a, and myostatin which 
causes muscle protein degradation. Thus, ECs might induce nerve damage as well as 
muscle damage. Since nerve damages including denervation trigger the muscle atrophy 
by protein degradation, if AMPK activation is result of nerve damage, it can be evidence 
that ECs induce nerve damage. Since model of denervation for nerve damage might be 
similar to a type of neurotmesis according to the Seddon’s classifications (Figure 1-7), it 
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does not coincide with induced nerve damage by ECs. However, model of NCI might be 
similar to nerve damage induced by ECs. Therefore, I hypothesized that NCI activates 
AMPK and regulates the expression of FoxO1, FoxO3a, and myostatin as denoted in 
chapter 2. 
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1-5 Table and Figures 
 
 
 
  Grade1 Grade2 Grade3 
Pain * ** *** 
Weakness X O O 
Loss of function  X X O 
  
Swelling Swelling 
Symptom 
 
Tenderness Tenderness 
   
Dislocation 
Recovery period Within two weeks About four weeks About six month 
 
Table 1-1. Grades of muscle strain 
Strains are divided into three grades. First grade is a mild strain. Some muscle fiber is damaged and can 
recover within two weeks. Second grade is also damaged muscle fibers. Recovery is accomplished by 
more than four weeks. Third grade is a severe injury with ruptured muscle fibers. About six months of 
periods is required for recovery. 
http://www.radiologyassistant.nl/en/p4a47de30059ba/muscle-mr-traumatic-changes.html 
http://www.humankinetics.com/excerpts/excerpts/understanding-muscle-strains 
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Figure 1-1. The division of tissue layers of skeletal muscle 
Skeletal muscle is made up with muscular tissues (muscle fibers) fibrous connective tissues and muscle 
fibers which are covered with sarcolemma. 
http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@7.1:65/Anatomy_&_Physiology 
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Figure 1-2. The components of muscle fiber 
Muscle fiber is filled by myofibril and sarcoplasm. The sarcoplasmic reticulum and T-tubule are located 
in sarcoplasm 
http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@7.1:65/Anatomy_&_Physiology 
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Figure 1-3. The structure of sarcolemma and role of T-tubule and Sarcoplasmic reticulum 
The action potential in muscle fiber is transmitted to T-tubule and then Sarcoplasmic reticulum releases 
calcium ions for muscle contraction.  
http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@7.1:65/Anatomy_&_Physiology 
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Figure 1-4. The structure of sarcomere and myofibril (thick and thin filament) 
The thin filament consists of actin, tropomyosin, and troponin and the thick filament is made up of the 
myosin protein. When myosin heads combine to actin, myofibril is contracted and force is generated. 
http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@7.1:65/Anatomy_&_Physiology 
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Figure 1-5. The stage of muscle contraction through nerve impulse transmission 
The stage of muscle contraction can be explained by the following four major phases; 1) Excitation (①), 
2) Excitation-contraction coupling (②~③), 3) Contraction (④), and 4) Relaxation (⑤~⑦).  
https://www.boundless.com/biology/textbooks/boundless-biology-textbook/the-musculoskeletal-system-3
8/muscle-contraction-and-locomotion-218/excitation-contraction-coupling-828-12071/images/fig-ch38_0
4_06/ 
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Figure 1-6. The cross section of myelin sheath and axon 
In PNS, axons are wrapped in a myelin sheath formed from the plasma membrane of Schwann cell [1]. 
http://www.nature.com/nrn/journal/v6/n9/full/nrn1743.html 
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Figure 1-7. Seddon’s classification about nerve injury 
According to Seddon’s classification [2], grades of nerve injury are divided into three grades [76]. 
http://www.scielo.br/img/revistas/anp/v71n10/0004-282X-anp-71-10-0811-gf01.jpg 
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Figure 1-8. Major protein degradation systems 
It has been reported that there are four mechanisms in protein degradation [27].  
http://openi.nlm.nih.gov/detailedresult.php?img=3153876_pjab-87-287-g002&req=4 
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Figure 1-9. Molecular mechanisms of protein synthesis and degradation in skeletal muscle 
Muscle activation induces protein synthesis and suppresses protein degradation. On the contrary, 
myostatin stimulates protein degradation and inhibits protein synthesis.  
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Chapter 2. 
The possible role of AMP-activated protein kinase 
(AMPK) in skeletal muscle degradation after eccentric 
contractions 
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2-1 Purpose 
The purpose of this study was to investigate what the cause was for inducing 
muscle protein degradation by ECs. In this study, I hypothesized that AMPK plays a key 
role in regulating the expression of atrophy-related factors in rat gastrocnemius in 
response to ECs with severe ankle joint torque deficit. To evaluated the effect of ECs, 
the expression levels of phosphorylated AMPK and phosphorylated Acetyl CoA 
carboxylase (ACC), which are well-known markers for AMPK activation [52], and  
expression levels of FoxO1, FoxO3a, and myostatin were measured. Also,, changes in 
the levels of phosphorylated FoxO1, FoxO3a, and myostatin in L6 myotube cells in 
response to treatment with AICAR was measured. 
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2-2 Materials and Methods 
 
Animal Care 
Male Wistar rats (age, 11 weeks; body mass, 344–398 g; n = 18) were randomly 
assigned to the following three groups: a 180EC group (180EC; eccentric contractions 
with 180°/s angular velocity; n = 6), a 30EC group (30EC; eccentric contractions with 
30°/s angular velocity; n = 6), and a control group (CON; n = 6). The angular velocities 
in the 180EC and 30EC groups were chosen in accordance with conditions set in 
previous study [25]. The rats were individually housed in ventilated cage (IVC) systems 
(Tecniplast, Milan, Italy) maintained at 22–24°C with a 12-h light/dark cycle. Rats were 
provided water and food ad libitum. No significant differences were found in weight 
between the groups (Data not shown). At 7 days after ECs, 6 rats in each group were 
dissected and weighed. This study was approved by the Ethical Committee for Animal 
Experiments at the Nippon Sport Science University. 
 
Measurement of ankle joint torque 
Ankle joint torque was measured as previously reported [77]. In brief, the right 
hind limbs of all the animals were shaved, and each rat was then anesthetized with 
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isoflurane. (aspiration rate, 450 mL/min; concentration, 2.0%). The anesthetized 
animals were used for isometric tetanic torque. Measurements were made before ECs 
and on days 1, 2, 3, 5, and 7 after ECs. For the control rats, only ankle joint torque was 
measured. 
 
ECs of the medial gastrocnemius muscle 
The EC system of the medial gastrocnemius muscle was similar to that observed 
in previous study [25, 77, 78]. After measurement of the ankle joint torque, the 180EC 
and 30EC groups were anesthetized and placed prostrate on the isokinetic dynamometer. 
The triceps surae muscle of the right hind limb was then electrically stimulated. ECs 
were induced at 180°/s (180EC) or 30°/s (30EC). The range of forced lengthening 
contraction was from 0° to 45°. The ECs comprised 4 sets of 5 contractions, and the 
interval between each set was 5 min. The control group was only anesthetized and no 
other treatment was received. After the last measurement of ankle joint torque, the 
muscle specimens were dissected, weighed, immediately frozen in liquid N2, and stored 
at –80°C until analysis. 
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Cell culture 
L6 rat myoblasts obtained from the Japanese Collection of Research Bioresources 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) + 10% fetal bovine 
serum. Fusion of subconfluent myoblasts was induced by changing the medium to 
DMEM + 3% horse serum for seven days. Prior to initiation of the experiments, L6 
myotubes were incubated in serum-free DMEM for 24 h. AICAR was added to the 
medium at a final concentration of 0, 0.1, 0.5, 1, 1.5, and 2 mM, and cells were 
maintained for 24 h. For western blot analysis, cells were harvested by scraping in RIPA 
buffer (#9808; Cell Signaling Technology, Danvers, MA, USA) and homogenized with 
a protease and phosphatase inhibitor cocktail (#78441; Thermo Scientific, Rockford, 
USA).  
 
Western blotting analysis 
The medial gastrocnemius muscle was macerated in liquid N2 and homogenized 
in a buffer containing 50 mM Tris-Cl (pH 7.4), 150 mM NaCl, 5 mM 
ethylenediaminetetraacetic acid (EDTA), 0.5% sodium dodecyl sulfate (SDS), 1% 
deoxycholate, 0.1% Triton X-100, 1% Nonidet P-40 (NP-40), 0.05% mercaptoethanol, 
10 mg/mL phenylmethylsulfonyl fluoride (PMSF), 0.5 mg/mL leupeptin, 0.2 mg/mL 
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aprotinin, and 1 mM Na3VO4. The homogenate was centrifuged at 16,000 ×g for 15 
min at 4°C. Protein concentrations were determined using a protein concentration 
determination kit (Protein Assay II; Bio-Rad, Richmond, VA). A 30-μg (rat samples) or 
20-μg (cell samples) total protein extracts from each sample were mixed with sample 
buffer, boiled, loaded on the same SDS-polyacrylamide gel (5 or 10%), and 
electrophoresed at 20 mA. The samples were electrophoretically separated at 180 mA 
for 90 min and separated proteins were then transferred onto polyvinylidene difluoride 
(PVDF) membranes (ATTO, Tokyo, Japan) or nitrocellulose membranes (GE healthcare, 
Whatman, Germany). The membranes were blocked for 1 h with phosphate-buffered 
saline (PBS) containing 5% skimmed milk and then incubated overnight at 4°C with the 
following primary antibodies (dilution, 1:1000): anti-AMPK alpha (#2532; Cell 
Signaling Technology), anti-p-AMPK alpha (Thr172) (#2535S; Cell Signaling 
Technology), anti-p-Acetyl-CoA Carboxylase (Ser79) (#3661S, Cell Signaling 
Technology), anti-FoxO1 (#9454S; Cell Signaling Technology), anti-p-FoxO1 (Ser256) 
(#9461S; Cell Signaling Technology), anti-FoxO3 (#2497S; Cell Signaling Technology), 
anti-p-FoxO3(Ser253) (#9466S; Cell Signaling Technology), anti-α-Tubulin (#2125; 
Cell Signaling Technology), and anti-myostatin (AB3239; Millipore, Billerica, MA). 
The membranes were then washed three times and incubated with the secondary 
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antibody at room temperature. Horseradish peroxidase (HRP)-conjugated goat anti-rat 
immunoglobulin G (IgG) or anti-rabbit IgG (dilution, 1:10,000) was used as the 
secondary antibody. Chemiluminescent reagents were used for detecting the secondary 
antibody (SuperSignal West Dura; Pierce Protein Research Products, Rockford, IL). 
Chemiluminescent signals were detected using a chemiluminescence detector (AE6961; 
ATTO) and quantified using a personal computer with image analysis software (CS 
Analyzer; ATTO). The band densities were expressed relative to those obtained for the 
control. 
 
Statistical analysis 
All values are expressed as mean ± standard deviations. One-way analysis of 
variance (ANOVA) followed by the Bonferroni test was used to compare the body mass, 
muscle wet weight, protein levels, and mechanical parameters with the exception of 
time course data. Two-way ANOVA followed by the Bonferroni test was used to test 
time course changes in ankle joint torque (time × groups). The significance level was set 
at P < 0.05. 
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2-3 Results 
 
Body mass and muscle wet weights 
No significant changes were observed between the groups with respect to either 
body mass or the wet weights of the medial gastrocnemius, lateral gastrocnemius, 
plantaris, and soleus muscles (Data not shown). 
 
Effect of ECs on ankle joint torque 
Figure 1 shows the isometric ankle joint torque deficit before and after ECs. 
Ankle joint torque was significantly lower in the 180EC group compared with the 30EC 
group at all times points (days 1, 3, and 5 post ECs, P < 0.05; day 2 post ECs, P < 0.01; 
Figure 2-1). In addition, compared with pretreatment values, significant torque deficit 
was observed in the 180EC group at all times points (day 1, 5, and 7 post ECs, P < 0.05; 
days 2 and 3 post-ECs, P < 0.01; Figure 2-1), whereas no such deficit was observed in 
the 30EC group.  
 
Effect of ECs on AMPK levels and activity in medial gastrocnemius muscle 
On day 7 post-ECs, the medial gastrocnemius muscle was removed for western 
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blot analysis. On day 7 post-180EC, levels of phosphorylated AMPKα in the 180EC 
group were significantly higher than those in the CON (P < 0.05) and 30EC (P < 0.01) 
groups (Figure 2-2A), while no significant differences were observed between CON and 
30EC (Figure 2-2A). 
Given that acetyl-CoA carboxylase (ACC) is a substrate for AMPK, levels of 
phosphorylated ACC are taken to reflect AMPK activity [52]. Compared with the CON 
group, levels of phosphorylated ACC at day 7 post-ECs were significantly higher in the 
180EC (P < 0.01) and 30EC (P < 0.05) groups (Figure 2-2B). 
 
Effect of ECs on FoxO1, FoxO3a, and myostatin levels in medial gastrocnemius 
muscle 
Day 7 post-ECs levels of FoxO1 and FoxO3 were significantly higher in the 
180EC group compared to the CON (P < 0.001, P < 0.05) and 30EC (P < 0.01, P < 
0.01) groups (Figure 2-3A and 2-3C), whereas no significant difference was observed in 
the levels of phosphorylated FoxO1 and FoxO3a among all the groups (Figure. 2-3B 
and 2-3D).  
Myostatin levels on day 7 post-ECs were significantly higher in the 180EC group 
compared with the 30EC (P < 0.001) and CON (P < 0.01) groups (Figure 2-4). 
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Effect of AICAR on levels of FoxO1, FoxO3a, and myostatin in L6 myotubes 
 Levels of the phosphorylated AMPK α subunit and phosphorylated ACC in L6 
myotubes increased in an AICAR concentration-dependent manner (Figure 2-5A and 
2-5B). Furthermore, relative contents of phosphorylated FoxO1 and FoxO3a to the total 
became lower in AICAR concentration-dependent manner (Figure 2-6A and 2-6B). 
Finally, levels of myostatin in L6 myotubes increased in an AICAR concentration- 
dependent manner (Figure 2-7). 
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2-4 Discussion 
In previous study [25], although Ochi et al. found that FoxO1, FoxO3a, and 
myostatin were induced in response to severe (180°/s angular velocity) eccentric 
contractions with ankle joint torque deficit, the molecular mechanisms of this 
phenomenon were unclear. In this study, severe eccentric contractions were able to 
stimulate both overall phosphorylated levels and activity of AMPK up to day 7 
post-180EC. I confirmed that the 180EC effect increases in day 7 post-ECs levels of 
FoxO1, FoxO3a, myostatin, as well as in phosphorylated AMPK-alpha and ACC. 
Indeed, even ECs without significant torque deficits (30EC group) induced ACC 
phosphorylation. Moreover, I have demonstrated that AMPK activation with AICAR in 
L6 myotubes reduces levels of phosphorylated FoxO3a and FoxO1 and increases 
myostatin levels, both in a concentration-dependent manner.  
Since ACC is a substrate for AMPK, phosphorylated ACC content is associated 
with AMPK activity [52], and I hypothesized that ECs would elevate AMPK activity. 
AMPK is known to be activated by exercise, and the activation of AMPK is regulated 
by intensity of exercise [79-82]. Furthermore, a number of studies have suggested that 
regulation of skeletal muscle AMPKα1 and α2 differs depending on exercise intensity. 
AMPKα2 is activated during exercise at or above 60% VO2 peak [80, 82, 83], whereas 
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AMPKα1 is activated only during intense sprint-type exercise in humans [80-83]. Since 
Thomson et al. [52] and Atherton et al. [84] showed that muscle contraction with high 
electrical stimulation did not elicit total AMPKα phosphorylation and activation using 
rats, it is not determined if AMPKα phosphorylation and activation is dependent to 
intensity.  
In this study of chapter 2, I confirmed that, as reported previously [25], FoxO 
protein levels are elevated on day 7 post-180EC. Since it has been reported that AMPK 
induces levels of FoxO proteins, muscle RING finger 1, and atrogin-1 in vivo and in 
vitro [51, 54, 85], I conclude that hyper activation of AMPK in the 180EC group 
supports elevated levels of FoxOs in vivo. Furthermore, I confirmed that myostatin 
levels on days 7 post-180EC were significantly higher compared to the CON and 30EC 
groups. Given that FoxO1 and SMADs bind to the myostatin promoter [55], I speculate 
that elevated levels of FoxO1 contribute to higher expression of myostatin in response 
to 180EC. With regard to the relationship between AMPK and myostatin, Chen et al. 
reported that AMPK is activated by myostatin, leading to the promotion of glycolysis 
[86]. Also, both expression and activity of AMPK in myostatin-null mutant mice was 
found to be higher than in wild-type mice [87]. However, from the previous study that 
reports AMPK regulate myostatin [88], I speculate that expression of myostatin is 
48 
 
induced by AMPK activation on day 7 post-180EC. 
I used an in vitro cell culture system to examine the effects of the AMPK activator, 
AICAR, on levels of FoxO proteins and myostatin. Previous studies have shown that 
AICAR stimulates FoxO mRNA and protein expressions in C2C12 myotubes [54]. In 
contrast, another study showed that AICAR and another AMPK agonist, metformin, 
decreased FoxO mRNA levels in C2C12 myotubes [85]. Neither of these studies, 
however, analyzed the effect of AMPK agonists on levels of phosphorylated FoxO 
proteins. It has been shown that AICAR decreases levels of phospho-FoxO3a in the 
cytoplasm of C2C12 cells, suggesting that FoxO3a may relocate to the nucleus in these 
cells [89]. Moreover, AICAR treatment has been demonstrated to attenuate rat 
cardiomyocyte hypertrophy and to effect a decrease in the ratio of the phosphorylated: 
unphosphorylated forms of FoxO1 [90].  
In this study, I found that levels of phospho-FoxO1 and phospho-FoxO3a were 
down-regulated in an AICAR concentration-dependent manner, suggesting that 
activated AMPKs regulate the relative phosphorylated states of FoxO1 and FoxO3a in 
rat L6 myotubes. This result is in agreement with a previous study [89] showing that 
AICAR treatment of C2C12 myotubes activated AMPK and decreased FoxO3a 
phosphorylation, although this study did not examine overall FoxO1 levels or levels of 
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phospho-FoxO1. Using an in vitro kinase assay, Greer et al. showed that activated 
AMPK resulted in specific phosphorylation of FoxO3a but did not target FoxO1, FoxO4, 
or FoxO6 for phosphorylation [91]. Conversely, it has been shown that AICAR 
treatment regulates levels of FoxO1 in hepatic HepG2 cells [92]. Based on all these 
results, I speculated that both FoxO1 and FoxO3a are subjected to AMPK regulation, at 
least in muscle cells. 
Evidence suggested that a similar relationship might exist between AMPK and 
myostatin levels. I confirmed in this study that 180EC stimulated myostatin levels and 
that myostatin levels in L6 cells were induced in an AICAR concentration-dependent 
manner. As alluded to earlier, Zhang et al. [87] and Chen et al. [86] have demonstrated 
that myostatin regulates both levels and activity of FoxO proteins. Furthermore, it has 
been reported that AMPK activation induces myostatin expression in C2C12 cells [88]. 
From the result where myostatin levels increase in an AICAR concentration-dependent 
manner suggests that myostatin is regulated as a downstream of AMPK. 
In summary, I demonstrated elevated levels of AMPK activation on day 7 after 
180EC with ankle joint torque deficits. Furthermore, AMPK activation reduced levels of 
the phosphorylated forms of FoxO1 and FoxO3a and stimulated myostatin levels, both 
in a concentration-dependent manner in L6 myotubes. Thus, I conclude that AMPK 
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activation plays an important role in the regulation of FoxO1, FoxO3a, and myostatin 
activity, and these results could explain the elevation of total FoxO1, FoxO3a, and 
myostatin levels in response to 180EC. Additional studies are required to clarify the 
observation that AMPK is activated on day 7 post-180EC. 
Taken together, I consider that 180EC result in both AMPK activation and 
phosphorylation of AMPKα, whereas 30EC induce only AMPK activation 
(phosphorylation of ACC). 
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2-5 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1. Time course changes of rat ankle joint torque after eccentric contractions 
180EC: eccentric contractions with 180°/s angular velocity, 30EC: eccentric contractions with 30°/s 
angular velocity. The values are expressed as mean ± SD. *P < 0.05, **P < 0.01, 180EC vs. 30EC. †P < 
0.05, ††P < 0.01, 180EC vs. pretreatment value. 
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Figure 2-2. Levels of relative phosphorylated AMPK (A) and Phosphorylated ACC (B) on day 7 
post-ECs  
180EC: eccentric contractions with 180°/s angular velocity, 30EC: eccentric contractions with 30°/s 
angular velocity, CON: control group. The values are expressed as mean ± SD. (A) *P < 0.05, **P < 0.01, 
vs. 180EC. (B) †P < 0.05, ††P < 0.01, vs. CON. 
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Figure 2-3. Levels of FoxO1(A) and FoxO3a(B) and phosphorylated FoxO1(C) and FoxO3a(D) on 
day 7 post-ECs  
180EC: eccentric contractions with 180°/s angular velocity, 30EC: eccentric contractions with 30°/s 
angular velocity, CON: control group. The values are expressed as mean ± SD. *P < 0.05, **P < 0.01, 
***P < 0.001, vs. 180EC.  
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Figure 2-4. Level of myostatin on day 7 post-ECs 
180EC: eccentric contractions with 180°/s angular velocity, 30EC: eccentric contractions with 30°/s 
angular velocity, CON: control group. The values are expressed as mean ± SD.  
***P < 0.001, vs. 180EC.  
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Figure 2-5. Effect of AICAR treatment on phosphorylated AMPK(A) and ACC(B) level in L6 
myotubes 
L6 myotubes were treated with different concentration (0mM, 0.1mM, 0.5mM, 1mM, 1.5mM, 2mM).  
The values are expressed as mean ± SD (n = 6). *P < 0.05, vs. 0mM. 
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Figure 2-6. Effect of AICAR treatment on phosphorylated FoxO1(A) and FoxO3a(B) to the total 
level in L6 myotubes 
L6 myotubes were treated with different concentration (0mM, 0.1mM, 0.5mM, 1mM, 1.5mM, 2mM).  
The values are expressed as mean ± SD (n = 6). *P < 0.05, vs. 0mM. 
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Figure 2-7. Effect of AICAR treatment on myostatin level in L6 myotubes 
L6 myotubes were treated with different concentration (0mM, 0.1mM, 0.5mM, 1mM, 1.5mM, 2mM).  
The values are expressed as mean ± SD (n = 6). *P < 0.05, vs. 0mM. 
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Chapter 3. 
Severe eccentric contractions accompanying muscle 
injury induce structural damage and functional 
deficits of the peripheral nerve in rats 
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3-1 Purpose 
The aim of chapter 3 was to investigate whether ECs with fast angular velocities 
to the gastrocnemius muscle damage the sciatic nerve by measure of NCV and 
molecular analyses. I hypothesized that gastrocnemius muscle inducing muscle protein 
degradation by ECs produces structural damage and functional deficits to the sciatic 
nerve and its branches. 
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3-2 Materials and Methods 
 
Animal care 
Male Wistar rats were purchased from CLEA Japan, Inc. (Tokyo, Japan). Rats 
(age, 11 weeks; body mass, 285–358 g; n = 66) were assigned randomly to 1 of 3 
groups: a 180EC group (180EC; ECs with 180°/s angular velocity; n = 30), a 30EC 
group (30EC; ECs with 30°/s angular velocity; n = 30), and a control group (CON; n = 
6). Rats in the 2 ECs groups were further assigned to day-3-, day-7-, and day-10- 
subgroups (n = 10 each). The angular velocities in the 180EC and 30EC groups were 
chosen based on previous studies [25, 93]. All rats were housed in individually 
ventilated cage systems (Tecniplast S.p.A., Milan, Italy) that were maintained at 22–
24°C with a 12:12-h light: dark cycle and they were provided with water and food ad 
libitum. The right hindlimbs of all rats were shaved, and each rat was anesthetized with 
isoflurane. ECs were induced, and torque and NCV were measured while rats were 
anesthetized. Three, 7, and 10 days after the ECs, the rats in each group were sacrificed, 
and the gastrocnemius and soleus were dissected and weighed. The control group did 
not undergo ECs, but their gastrocnemius and soleus were also dissected and weighed 
after 7 days with the ECs groups. A portion of the sciatic nerve was excised from the 
61 
 
branching point of the sural nerve to the branching point of medial gastrocnemius nerve, 
as shown in Figure 1. Experimental procedures were approved by the Ethical 
Committee for Animal Experiments at the Nippon Sport Science University. 
 
ECs of the gastrocnemius muscle 
The ECs system of the gastrocnemius muscle was similar to that used in previous 
studies [25, 93]. Briefly, before the ECs, anesthetized rats were placed in a prone 
position on the isokinetic dynamometer. The gastrocnemius muscle of the right 
hindlimb was stimulated percutaneously with self-adhesive surface electrodes (Vitrode 
V, Ag/AgCl; Nihon Koden, Tokyo, Japan) connected to an electronic stimulator and an 
isolator (SS-104J; Nihon Koden, Tokyo, Japan). ECs were induced at 30°/s angular 
velocity (30EC) or 180°/s angular velocity (180EC) by electrical stimulation of the 
gastrocnemius muscle with simultaneous forced dorsiflexion of the ankle joint. The 
forced lengthening contractions ranged from 0° to 45°. Four sets of 5 contractions were 
induced, with a 5-min interval between each set. The control group was anesthetized 
only and received no other treatment. In order to confirm a functional deficit, isometric 
tetanic forces were measured at predetermined times before and after the ECs. Isometric 
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tetanic torque was measured as reported previously [25]. After the last measurement of 
isometric tetanic torque, the target muscles (gastrocnemius and soleus) and the sciatic 
nerve specimens (shown in Figure 3-1) were dissected, weighed, rapidly frozen in liquid 
N2, and stored at -80°C until analysis (n = 6 in each group). 
 
NCV 
To confirm sciatic nerve damage, NCV was measured with the method reported 
previously [94-96]. Concisely, the sciatic nerve of the anesthetized rats was exposed. 
Hook-type stainless-steel electrodes (EKM2-5050, BioResearch center, Tokyo, Japan) 
were placed at 2 different points on the sciatic nerve (Figure 3-1). The first stimulating 
electrode (S1) was placed near the branching point of the pudendal nerve, and the 
second electrode (S2) was placed near the branching point of the tibial nerve. 
Stimulation was performed with an electronic stimulator (SES-3301, Nihon Kohden 
Corporation, Tokyo, Japan). M-waves were recorded with a tripolar needle electrode 
(EKI-2010, Bio Research Center) inserted into the mid-belly of the medial 
gastrocnemius muscle. The signals were converted digitally with Power Lab/16SP (AD 
Instruments Japan Inc., Nagoya, Japan). 
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NCV was analyzed with Power Lab Chart 7 (AD Instruments Japan Inc.) with the 
data for the latencies of these 2 stimulation points. NCV was calculated as the distance 
between S1 and S2 divided by the latencies of the waveforms generated by stimulation 
at the 2 sites. The NCV of the left sciatic nerve served as an internal control for each 
group. NCV was measured for 4 rats in each group. After measuring NCV, the rats were 
sacrificed and were not used in further analyses. 
 
Western blotting analysis 
The right sciatic nerve branch was homogenized in buffer containing 50 mM Tris 
HCl (pH 7.4), 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid, 0.5% sodium 
dodecyl sulfate, 1% deoxycholate, 0.1% Triton X-100, 1% Nonidet P-40, 0.05% 
mercaptoethanol, 10 mg/mL phenylmethylsulfonyl fluoride, 0.5 mg/mL leupeptin, 0.2 
mg/mL aprotinin, and 1 mM Na3VO4. The homogenate was centrifuged at 16,000 × g 
for 15 min at 4°C. Protein concentration was determined with a protein concentration 
determination kit (Protein Assay II; Bio-Rad Laboratories, Inc., Richmond, VA, USA). 
An aliquot of each sample containing 15 µg of total protein extract was diluted with 
sample buffer, boiled at 85°C, loaded in the same sodium dodecyl 
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sulfate-polyacrylamide gel (10% or 12.5%), and separated by electrophoresis. The 
samples were transferred to polyvinylidene difluoride membranes (ATTO Corporation, 
Tokyo, Japan), blocked for 1 h with 2% skim milk, and then incubated overnight at 4°C 
with the following primary antibodies (all diluted 1:1,000): anti-myelin protein zero 
antibody (rabbit polyclonal ab31851; Abcam plc, Cambridge, UK), anti-gap-43 
antibody (rabbit polyclonal antibody H-100; Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA, USA), anti-TrkC antibody (rat monoclonal antibody MAB1404; R&D 
Systems, Inc., Minneapolis, MN, USA), anti-rat macrophage antibody (mouse 
monoclonal antibody T-3003; BMA Biomedicals, Augst, Switzerland), and anti-β-actin 
antibody (mouse monoclonal antibody 3700s; Cell Signaling Technology, Inc., Danvers, 
MA, USA). The membranes were then incubated with the secondary antibody for 2 h at 
room temperature. Horseradish peroxidase-conjugated goat anti-rat immunoglobulin G 
(IgG), anti-rabbit IgG (dilution, 1:10,000), or anti-mouse IgG (dilution, 1:10,000) was 
used as the secondary antibody. Chemiluminescent signals were detected with 
chemiluminescent reagents (SuperSignal West Dura; Thermo Fisher Scientific Inc., 
Rockford, IL, USA) and scanned with a chemiluminescence detector (AE6961; ATTO 
Corporation). All data were quantified with a software package (CS Analyzer; ATTO 
Corporation) and expressed relative to the levels obtained for the control group. 
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Immunohistochemistry 
The harvested sciatic nerve segments were fixed with 4% paraformaldehyde 
overnight at 4°C and dehydrated in 30% sucrose in 0.1 M phosphate buffer (pH 7.4) for 
6 h at 4°. The sciatic nerve segments were then embedded in OCT compound and 
frozen in liquid N2. The frozen samples were stored at -80°C. Cross-sections (10-µm in 
thickness) were cut with a cryostat at -20°C and mounted on glass slides. The glass 
slides were then washed 3 times for 10 min. In order to block any nonspecific reactions, 
the sections were blocked for 1 h with 0.1 M phosphate-buffered saline (PBS) 
containing 1% bovine serum albumin and 0.01% Triton X-100. The sections were then 
incubated overnight at 4°C with the primary antibodies, including an anti-TrkC 
antibody (rat monoclonal antibody, diluted 1:300, R&D Systems, Inc.), which were 
diluted in 0.1 M PBS containing 1% bovine serum albumin and 0.01% Triton X-100. 
The sections were washed 3 times with 0.1 M PBS and incubated overnight at 4°C with 
the secondary antibody, Texas red-labeled goat anti-rat IgG (Vector Laboratories, Inc., 
Burlingame, CA, USA, 1:500), that was diluted in 0.1 M PBS containing 1% bovine 
serum albumin and 0.01% Triton X-100. The sections were washed 3 times with 0.1 M 
PBS, rehydrated in 0.1 M PBS containing 0.2% Triton X-100 for 20 min at room 
temperature, and stained with Fluorescent Myelin Stains (1:300, Green Fluorescent 
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Myelin Stains, F 34651) that were diluted in 0.1 M PBS containing 0.2% Triton X-100 
for 20 min at room temperature. After the staining was complete, the solution was 
removed, and the sections were washed 3 times with 0.1 M PBS for 10 min. The 
sections were coverslipped with mounting medium containing 
4′,6-diamidino-2-phenylindole (Vectashield, Vector Laboratories, Inc.) and viewed with 
a florescence microscope (Olympus model BX 60; Olympus Corporation, Tokyo, 
Japan). The images were captured with a digital camera (Olympus model DP 70; 
Olympus Corporation) and analyzed with Olympus DP 70 controller software. 
 
Statistical analysis 
Two-way ANOVA was used to compare the body mass, the muscle wet weights, 
the changes in isometric tetanic torque over time, NCVs, and protein expression levels. 
Post hoc tests were performed by Bonferroni tests. All values are expressed as mean ± 
standard deviation. P values less than 0.05 were considered statistically significant. 
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3-3 Results 
 
Physiological change in gastrocnemius muscle and sciatic nerve after ECs 
After the ECs, no significant differences in the wet weights of the soleus muscles 
were observed among the 3 groups. However, the wet weights of the gastrocnemius 
muscles in the 180EC group were significantly increased on day 3 (4.99 mg/ gram body 
weight) compared to those on day 10 (4.61 mg/ gram body weight) (P < 0.05) (Table 
3-1).  
Isometric tetanic torque was measured after the ECs. The isometric tetanic torque 
of the 180EC group remained significantly lower than that of the 30EC group until day 
7 after the ECs (day 7, P < 0.05; day 1, day 2, day 3, and day 5, P < 0.01) (Figure 3-2). 
Moreover, significant torque deficits relative to the pretreatment values were observed 
in the 180EC group from days 1 to 5 after the ECs (day 1, day 3, and day 5, P < 0.01) 
(Figure 3-2). In contrast, no torque deficits were observed in the 30EC group. 
In order to examine the functional nerve damage caused by the ECs, the NCVs 
were examined. NCVs in the 180EC group on day 7 after the ECs were significantly 
lower than those in the control group (P < 0.05) (Figure 3-3A). No significant 
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differences were observed between the 30EC groups and the 180EC groups (Figure 
3-3B). 
 
Change in molecular expressions of gastrocnemius muscle and sciatic nerve after 
ECs 
The levels of myelin sheath protein zero (p0) which decreases when the myelin 
sheath is damaged were examined.[67, 97] On day 7 after the ECs, the p0 content was 
significantly lower in the 180EC group than in the 30EC group (P < 0.05) (Figure 3-4A). 
In addition, the p0 content differed significantly between the day-3 and day-7 180EC 
groups (P < 0.05) (Figure 3-4A). In contrast, the p0 content in the 30EC group remained 
almost the same after the ECs. No significant differences between the GAP-43 contents 
were observed (Figure 3-4B). 
The levels of the macrophage related protein (ED1) after the ECs were measured. 
The ED1 levels of the 180EC group were significantly higher on day 7 than on day 3 (P 
< 0.05) (Figure 3-4C). Significantly higher ED1 levels in the 180EC groups were also 
observed in comparison with the levels of the 30EC group on day 7 after the ECs (P < 
0.01) (Figure 3-4C). 
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TrkC levels in the 180EC group were significantly higher on day 7 than on day 3 
or day 10 (P < 0.01) (Figure 3-4D). TrkC levels on day 7 were also significantly higher 
in the 180EC group than in the 30EC group (P < 0.05) (Figure 3-4D). In addition, 
localization of TrkC was observed by immunohistochemistry. Immunoreactive signals 
of TrkC were detected in the myelin sheath, suggesting that TrkC localized Schwann 
cells around myelin. Strong TrkC signals were observed only in the 180EC group on 
day 7 after the ECs (Figure 3-5). 
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3-4 Discussion 
The significant decrease in NCVs and p0 levels on day 7 only in the 180EC 
suggests that the myelin sheath was damaged by ECs with a 180°/s angular velocity. 
Using ED1 as a marker for rat macrophages when sciatic nerve is damaged [98], the 
significant increases in ED1 levels in the 180EC group would be consistent with an 
inflammatory reaction in the sciatic nerve and its branches innervating the 
ECs-damaged gastrocnemius muscle. The increase in TrkC levels in the 180EC group 
suggests that reconstruction of the nerve cells occurred. 
The greater wet weight of the gastrocnemius in the 180EC group on day 3 than on 
day 10 appears to be due to increased inflammation and swelling, based on the 
development of ultrastructural collapse, edema, and inflammation of myofibers [14, 99]. 
These lines of evidence suggest that muscles are seriously damaged on days 2–3 after 
ECs. Although several groups have reported that fast ECs velocities do not result in 
increased damage [100, 101], my data suggest that ECs with faster angular velocity 
(180°/sec) seriously damaged the gastrocnemius muscles, compared with slow angular 
velocity (30°/sec). 
Reductions in NCVs by diabetes and neurogenic diseases have been reported [102, 
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103]. Although muscle damage induced by ECs has not been reported to produce 
reductions in NCV, several reports suggest that ECs damage both muscle and nerve cells. 
Functional damage to the sciatic nerve by vigorous ECs is supported by the reduced 
NCVs of the 180EC group on day 7 after the ECs, in contrast to results in the 30EC 
group. 
I examined the molecular alterations of the sciatic nerve branch and found that the 
amount of p0 in the 180EC group was lower on day 7 than on days 3 or 10.  The 
myelin sheath consists of p0, MAG, and PMP22, and when the nerve is damaged, the 
levels of these proteins decrease [67, 97]. Although future studies should further 
evaluate MAG and PMP22 levels, the results that were obtained for p0 indicated that 
the myelin sheath was damaged after the 180EC. In addition, I showed that levels of a 
macrophage-related protein in the 180EC group on day 7 were greater than those in the 
180EC group on day 3 or the 30EC group on day 7. If the myelin sheath is damaged, 
macrophages increase in number in the damaged area of nerve cells [60, 62, 64, 65]. 
After re-myelination is complete, the macrophage numbers also return to baseline levels. 
Axon regeneration is characterized by formation of a growth cone. GAP-43 is expressed 
at high levels in neuronal growth cones during development and axonal regeneration 
[104]. On day 7 after the 180EC, p0 decreased, while GAP-43 did not differ 
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significantly among all groups. The same tendency was not observed in the 30EC 
groups. Taken together, these results suggest that the myelin sheath, but not the axon, 
was damaged after the detrimental ECs, as has been shown in neuropraxia [2]. From the 
results of the functional and molecular examinations, we conclude that the injury in the 
nerve cells was prominent on day 7 after the ECs. 
The NCV reductions and myelin sheath damage in the 180EC group were 
observed on day 7, suggesting that there was a delay between the ECs and nerve injury. 
Although we examined the sciatic nerve branch, I believe the ECs initially damaged 
motor unit, neuromuscular junctions and intramuscular nerve, as has been reported by 
others [57, 58, 71]. Kami et al. have reported that gastrocnemius contusion injuries 
induced intramuscular axonal damage with retrograde propagation to the cell body in 
the spinal cord [59]. They have shown that apparent damage in motor neurons and 
intramuscular nerves were observed 3 days after the muscle injury [59]. Furthermore, in 
cases of nerve crush injury, the sciatic function index and myelin thickness in damaged 
nerve have been shown to be affected 7 days after crush treatment [105, 106]. I think 
that the damage to nerve cells was initiated in the skeletal muscle, and it was then 
transmitted in a retrograde direction to the innervating nerves. These are 
time-consuming events. In addition, I found that disorders in the nerve cells occurred in 
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only the 180 EC groups, suggesting that strong eccentric contractions induced nerve 
damage. 
Schwann cell migration and proliferation provide an essential supportive function 
for the myelin sheath [68]. Schwann cells are also involved in many important aspects 
of peripheral nerve development and regeneration [4, 5]. NT-3 and TrkC are involved in 
Schwann cell migration [61]. In this study, I showed that the expression levels of TrkC 
in the 180EC group on day 7 were higher than those in the 180EC group on days 3 or 10 
or in the 30EC group on day 7. The 3 most common types of Trk receptors are TrkA, 
TrkB, and TrkC. Each of these receptor types has different binding affinities for certain 
types of neurotrophins. TrkC is ordinarily activated by binding NT-3. Because the 
activation of TrkC by NT-3 induces Schwann cell migration, higher levels of TrkC 
suggest that the damaged myelin sheath is being repaired by Schwann cells. I confirmed 
that TrkC expression was localized to Schwann cells around the myelin sheath, 
suggesting that Schwann cells were activated by TrkC after 180°/s ECs. BDNF 
activation of the p75 NTR is also involved in Schwann cell proliferation. The 
differences in the signaling pathways initiated by these distinct types of receptors are 
important for generating diverse biological responses. In addition, p75 NTR enhances 
myelination by binding to BDNF during neuronal regeneration [67, 68]. The 
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orchestration of these signaling molecules in nerve injuries that are induced by ECs 
should be examined further. 
Damage to the myelin sheath may reduce NCV and possibly cause muscle 
atrophy [106, 107]. Although we found reductions in NCVs, I did not observe decreased 
wet weights of examined muscles. However, Ochi et al. have reported that ECs with 
180°/s angular velocities induce higher expression levels of FoxO1 and FoxO3a [25]. 
Furthermore, they observed that 30EC did not induce the expression of FoxO proteins. 
As FoxO proteins lead to degradation of muscle proteins, muscles subjected to 180°/s 
ECs might atrophy. This catabolic process might be initiated by neural tissue damage. 
Because I used anesthetized animals, electrical stimulation, and a larger range of 
motion, factors other than ECs might have induced the neural tissue damage. In order to 
exclude these possibilities, I confirmed that the 30EC group did not show any 
indications of neural tissue damage, and thus concluded that a 180°/s angular velocity 
and resultant force deficits were key to the induction of neural tissue damage by ECs.  
I showed that ECs of the gastrocnemius muscle induce damage of the myelin 
sheath and cause reduction of NCVs, consistent with damage to nerve cells. I suspect 
that the damaged nerve might in turn exacerbate injured muscle, a concept which may 
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lead to novel ideas for prevention and treatment of ECs-induced muscle injury. Because 
it is not clear whether this animal model is relevant to injuries induced by voluntary 
action, future studies should assess whether voluntary ECs-related exercise affects the 
function of human nerve. 
In the study of chapter 3, I observed damage of the sciatic nerve on day 7 
post-180EC in rat gastrocnemius muscle [108]. Probably, sciatic nerve damage activates 
AMPK and activated AMPK induces protein degradation. Even if this is the case, this 
conclusion is well matched with the previous study showing [109] that AMPK 
activation with AICAR failed to prevent protein degradation in denervated 
gastrocnemius and soleus muscle. Although nerve crush injury has been found to induce 
elevated myostatin, AMPK activation has not been observed in response to nerve crush 
injury [75]. Therefore, in the chapter 4, I researched to determine whether protein 
degradation by nerve crush injury induces AMPK activation. 
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3-5 Table and Figures 
 
 
 
 
 
 
 
 
 
 
Table 3-1. Body weight and wet weight of soleus and gastrocnemius after ECs 
CON: the control group, 30EC: ECs with 30°/s angular velocity, 180EC: ECs with 180°/s angular 
velocity. BW: body weight, Sol: soleus, Gas: gastrocnemius. Values are expressed as the mean ± SD. *: P 
< 0.05 between groups. 
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Figure 3-1. Schematic representation of the sciatic nerve and its branches 
S1 (proximal): the branching point of pudendus nerve, S2 (distal): the branching point of tibialis nerve. 
Induced M-wave was taken at the mid-belly of medial gastrocnemius muscle (R). The black line of the 
sciatic nerve branch shows the tissue that was excised for western blotting and immunohistochemistry. 
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Figure 3-2. Time course changes in isometric tetanic torque after ECs 
The isometric tetanic torque in the 180EC group was decreased significantly compared with that of the 
30EC group and the pretreatment values. 30EC: ECs with 30°/s angular velocity, 180EC: ECs with 180°/s 
angular velocity. Statistical significance:*P<0.05, **P<0.01 180EC vs. pretreatment value; †P<0.05, 
††P<0.01, 180EC vs. 30EC. 
 
 
 
79 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3. Nerve conduction velocities after ECs 
(A) The NCV in the day-7 180EC group was decreased significantly compared with the control group.  
(B) NCVs in the 30EC groups were not decreased compared with the control groups. Open bars, internal 
control for each group; Black bars, ECs groups.30EC: ECs with 30°/s angular velocity; 180EC: ECs with 
180°/s angular velocity. Statistical significance: *P<0.05, 180EC vs. CON.  
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Figure 3-4. Contents of p0, GAP-43, ED1, and TrkC after ECs 
(A) Contents of p0 after ECs. The amount of p0 in the 180EC group was significantly lower on day 7 than 
on days 3 or 10. (B) Contents of GAP-43 after ECs. No significant changes were observed among the 
groups. (C) Invasion of macrophages into nerve tissue after ECs. (D) Immunoblotting for TrkC. 30EC: 
ECs with 30°/s angular velocity, 180EC: ECs with 180°/s angular velocity. Open bars, 30EC groups; 
Black bars, 180EC groups. Statistical significance: *P<0.05, **P<0.01, 180EC vs. 30EC; †P<0.05, 
††P<0.01, 180EC day7 vs. 180EC day3 or day10. 
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Figure 3-5. Immunohistochemistry of TrkC after ECs  
A strong TrkC signal relative to the 30EC group on day 7 was observed only in the 180EC group on day 
7 after the ECs.180EC: ECs with 180°/s angular velocity, 30EC: ECs with 30°/s angular velocity. 
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Chapter 4. 
Expressions of myostatin and MuRF1 have important 
roles on muscle protein degradation by nerve crush 
injury in rats 
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4-1 Purpose 
The object of chapter 4 was to identify whether AMPK activation occurs in 
muscle atrophy induced by the nerve crush injury (NCI). I hypothesized that AMPK 
activation stimulates the expression of muscle protein degradation-related factors like in 
chapter 2. Levels of phosphorylated AMPK and phospho-acetyl CoA carboxylase, and 
expression levels of FoxO1, FoxO3a, and myostatin were verified to elucidate 
relationship between AMPK activation and muscle protein degradation after NCI. 
Furthermore, these results support the hypothesis that nerve damage induced by ECs as 
shown in the chapter 3, is the cause for AMPK activation induced muscle protein 
degradation as seen in chapter 2. 
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4-2 Materials and Methods 
 
Animal care 
Male Wistar rats (age, 6 weeks; body mass, 260–280 g; n = 30) were randomly 
assigned to the following two groups: control group (sham operation group; n = 6) and 
nerve crush injury group (NCI, n = 24). Furthermore, NCI groups were divided into four 
groups for analysis of time course. The rats were individually housed in ventilated cage 
(IVC) systems (Tecniplast, Milan, Italy) maintained at 22–24°C with a 12-h light/dark 
cycle. Rats were provided water and food ad libitum. At 3 day, 7 day, 14 and 28 day 
after NCI, 6 rats in each group were dissected and weighed. This study was approved by 
the Ethical Committee for Animal Experiments at the Nippon Sport Science University. 
 
Surgical procedures of nerve crush injury 
NCI was conducted according to the previous reported study [75]. Briefly, the 
85 
 
right hind limbs of all the rats were shaved, and then each rat was anesthetized with 
isoflurane. (aspiration rate, 450 mL/min; concentration, 2.0%). The right sciatic nerve 
was exposed through an incision of the right hind leg and was crushed using a forcep 
clamping for 30 seconds. Left hind leg was left intact. Only incision of the skin was 
made in the sham-operated control group. After NCI, the incision of right hind leg was 
stitched and rats were returned to their cages. On days 3, 7, 14 and 28 after surgery, each 
group was dissected, weighed, immediately frozen in liquid N2, and stored at –80°C 
until analysis. 
 
Western blotting analysis 
The medial gastrocnemius muscle was macerated in liquid N2 and homogenized 
using a RIPA buffer (Pierce, Rockford, USA). The homogenate was centrifuged at 
16,000 ×g for 15 min at 4°C. Protein concentrations were determined using a protein 
concentration determination kit (Protein Assay II; Bio-Rad, Richmond, VA). A 30-μg 
86 
 
(rat samples) total protein extracts from each sample were mixed with sample buffer, 
boiled, loaded on the same SDS-polyacrylamide gel (5, 10, or 12.5%). The samples 
were electrophoretically separated and separated proteins were then transferred onto 
nitrocellulose membranes (GE healthcare, Whatman, Germany). The membranes were 
blocked for 1 h with tris-buffered saline (TBS) containing 1% triton X and 5% skimmed 
milk and then incubated overnight at 4°C with the following primary antibodies 
(dilution, 1:1000): anti-AMPK alpha (#2532; Cell Signaling Technology), anti-p-AMPK 
alpha (Thr172) (#2535S; Cell Signaling Technology), anti-p-Acetyl-CoA Carboxylase 
(Ser79) (#3661S, Cell Signaling Technology), anti-FoxO1 (#9454S; Cell Signaling 
Technology), anti-p-FoxO1(Ser256) (#9461S; Cell Signaling Technology), anti-FoxO3 
(#2497S; Cell Signaling Technology), anti-p-FoxO3(Ser253) (#9466S; Cell Signaling 
Technology), anti-GDF8 (sc-6884; Santacruz Biothechnology), anti-MuRF1(sc-32920; 
Santacruz Biothechnology), and anti-MAFbx (sc-33782; Santacruz Biothechnology). 
The membranes were then washed three times and incubated with the secondary 
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antibody at room temperature. Horseradish peroxidase (HRP)-conjugated goat 
anti-mouse immunoglobulin G (IgG) or anti-rabbit IgG (dilution, 1:10,000) was used as 
the secondary antibody. Chemiluminescent reagents were used for detecting the 
secondary antibody (SuperSignal West Dura; Pierce Protein Research Products, 
Rockford, IL). Chemiluminescent signals were detected using a chemiluminescence 
detector (AE9100N; ATTO) and quantified using a personal computer with image 
analysis software (CS Analyzer; ATTO). The band densities were expressed relative to 
those obtained for the control. 
 
Statistical analysis 
All values are expressed as mean ± standard deviations. One-way analysis of 
variance (ANOVA) followed by the Fisher exact test was used to compare the body 
mass, wet weight of gastrocnemius muscle, and expression of protein levels using a 
micro soft office excel. The significance level was set at P < 0.05. 
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4-3 Results 
 
Body mass and wet weight of gastrocnemius muscle following NCI 
Following the NCI, no significant differences in the body mass (Table 4-1) were 
observed among the each group. However, the wet weights of the right gastrocnemius 
muscles in the NCI group were significantly decreased until 28 days compared to 
control group after NCI. The wet weights of the right gastrocnemius muscles were 
gradually decreased and the group after NCI on day 14 was the lowest among all time 
points (Figure 4-1). 
 
Relationship between AMPK activation and muscle protein degradation in 
gastrocnemius muscle 
After NCI, AMPK activation was observed using levels of phosphorylated 
AMPKα and ACC. Although no significant difference in the levels of phosphorylated 
AMPKα was observed among each group on day 14 after NCI, the level of 
phosphorylated ACC was significantly higher than control group (Figure 4-2A and 
4-2B). 
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Effects of NCI on muscle protein degradation in gastrocnemius muscle 
In order to confirm the molecular mechanism of muscle protein degradation, the 
expression of FoxO1, FoxO3a, MAFbx, MuRF1 and myostatin was measured using a 
western blot analysis. As a result, the expression of myostatin gradually increased from 
on day 3 to day 28. The level of myostatin on day 14 after NCI was significantly higher 
compare to control group (Figure 4-3A). Similarly, myostatin receptor, Activin type II 
receptor (ActRIIb) was significantly higher compared to control group on day 14 after 
NCI (Figure 4-3B). Moreover, the expression of MuRF1 on day 3 after NCI was 
significantly higher than control group (Figure 4-4A). However, the expression of 
MAFbx was not significantly different among all time course of NCI (Figure 4-4B). 
Contrary to the skeletal muscle atrophy by NCI, the muscle protein degradation-related 
factor, FoxO1 was phosphorylated on day14 after NCI (Figure 4-5A). The 
phosphorylation of FoxO3a showed no significant differences among all time course of 
NCI (Figure 4-5B). 
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4-4 Discussion 
In the chapter 2 and 3, I found that higher expressions and/or activated 
phosphorylation states of FoxO1, FoxO3a, myostatin and AMPK were induced in 
response to severe (180°/s angular velocity) eccentric contractions accompanying with 
muscle and nerve damage. In this chapter, I showed that NCI stimulates levels of 
phosphorylated ACC on day 14 after NCI, as well as the elevated expression of 
myostatin likely in chapter 2. Furthermore, NCI increases the expression of MuRF1 on 
day 3 and on day 14 after NCI. On the contrary, levels of phosphorylated FoxO1 and 
FoxO3a on day 14 after NCI were significantly increased compare to control group. 
Since many studies have suggested that regulation of skeletal muscle AMPKα1 
and α2 differs depending on exercise intensity [79-82], no phosphorylated AMPKα but 
phosphorylated ACC could be supposed that different AMPK isotype would 
phosphorylate ACC. Especially in NCI, a consumption of ATP might be induced not by 
exercise but by regeneration of damaged muscle and nerve. The fashion of ATP 
consumption in regeneration process might differ from the situation in 
eccentric contraction exercise. In addition, I suspect whether AMPK activity always 
associate with phosphorylated states of ACC. Taken together, even though higher level 
of phosphorylated ACC was observed after NCI, another molecular mechanism, except 
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for AMPK alpha would play a role in this phenomenon. 
I observed that NCI regulates expression of strong atrophy-related factor, 
myostatin. As a previous study [75], our experimental model of ECs stimulates the 
expression of myostatin. Since high expression of myostatin has been reported on day 
14 after NCI in rat gastrocnemius muscle [75] by others, increased level of myostatin 
shown in this chapter is likely to a result of NCI. Probably, the sciatic nerve damage 
activates the expression of myostatin and up-regulates myostatin which might induce 
the muscle protein degradation. Although AMPK activation was only confirmed by 
ACC phosphorylation states after NCI treatment, expression of myostatin is 
undoubtedly induced by NCI. 
In this study, elevated expression of MuRF-1 was confirmed on day 3 and day 14 
after NCI. In previous studies of sciatic nerve dissection (usually stated as muscle 
denervation), it has been reported that the expression of MuRF-1 was induced during 
early stage (at 3 days) after muscle denervation [110]. Therefore, I have speculated that 
the increase of MuRF-1 appears in an early stage (at 3 days) and again up-regulated in a 
late stage (at 14 days) after NCI. I speculate that elevation of myostatin on day 14 after 
NCI might stimulate expression of MuRF-1 and, as a result, muscle atrophy reached its 
peak on day 14 after NCI. 
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Even though NCI elevated the expression of myostain and MuRF-1, FoxO1 and 
FoxO3a were phosphorylated. Since phosphorylated FoxO1 and FoxO3a mean suppress 
of muscle protein degradation, these results oppose with the results of myostatin and 
MuRF-1. However, one group reported that denervation atrophy is independent on Akt 
and mTOR activation and is not rescued by myostatin inhibition [111]. Moreover, they 
confirmed that phosphorylated FoxO3a did not change after denervation. Therefore, 
their results and my results are similar in the way that muscle protein degradation 
following nerve damages was not affected by the levels of FoxOs. 
In conclusion, I examined the possibility that elevated level of AMPK activation 
induces the expression of myostatin with muscle atrophy and nerve damage on day 14 
after NCI. As a result, I failed to confirm time course association of AMPK activation 
with the phosphorylated FoxO1 and FoxO3a. Thus, I conclude that the role of 
AMPK-FoxO axis is not so apparent in NCI induced muscle atrophy. With regard to 
myostatin and MuRF1, elevated expressions were observed on day 14, suggesting that 
myostatin induced muscle protein degradation is important in NCI induced muscle 
atrophy. 
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4-5 Table and Figures 
 
 
 
 
 
 
   CON  Day 3 Day 7 Day 14 Day 28 
BW (g) 283.11 ± 9.96 266.1 ± 17.16 280.3 ± 22.02 284.98 ±7.98 314.88 ± 9.30 
Gas/BW 
(mg/g) 
4.60 ± 0.16 3.92 ± 0.20 ** 3.26± 0.58 ** 2.69 ± 0.59 ** 3.82 ± 0.23 ** 
Gas (mg) 
1302.01 ± 
44.35 
1046.53± 
12.03 
917.53 ± 
19.77 
768.81 ± 
15.52 
1205.16± 
77.26 
 
Table 4-1. Body weight and wet weight of gastrocnemius after NCI 
CON: the control group, BW: body weight, Gas: gastrocnemius. The values are expressed as mean + SD. 
**P < 0.01, vs. CON. Post hoc tests were performed by Fisher exact test  
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Figure 4-1. The time course change in wet weight of gastrocnemius muscle (gas) after NCI 
The values are expressed as mean + SD. *P < 0.05, **P < 0.01, vs. CON. 
Post hoc tests were performed by Fisher exact test  
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Figure 4-2A. Level of phosphorylated AMPK until 28 day post-NCI 
The values are expressed as mean + SD.  
B 
 
 
 
 
 
 
 
Figure 4-2B. Level of phosphorylated ACC until 28 day post-NCI 
The values are expressed as mean + SD.  
*P < 0.05, vs. CON. Post hoc tests were performed by Fisher exact test  
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Figure 4-3A. The expression of myostatin until 28 day post-NCI 
The values are expressed as mean + SD.  
**P < 0.01, vs. CON. Post hoc tests were performed by Fisher exact test  
B 
 
 
 
 
 
 
Figure 4-3B. Level of ActRIIb until 28 day post-NCI 
The values are expressed as mean + SD.  
**P < 0.01, vs. CON. Post hoc tests were performed by Fisher exact test  
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Figure 4-4A. Expression of MuRF-1 until 28 day post-NCI 
The values are expressed as mean + SD.  
*P < 0.05, vs. CON. Post hoc tests were performed by Fisher exact test  
 
B 
 
 
 
 
 
 
 
 
 
Figure 4-4B. Expression of MAFbx until 28 day post-NCI 
The values are expressed as mean + SD.  
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Figure 4-5A. Level of phosphorylated FoxO1 until 28 day post-NCI 
The values are expressed as mean + SD.  
**P < 0.01, vs. CON. Post hoc tests were performed by Fisher exact test  
B 
 
 
 
 
 
 
 
 
Figure 4-5B. Level of phosphorylated FoxO3a until 28 day post-NCI 
The values are expressed as mean + SD.  
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Chapter 5. Summary and Perspective 
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5-1 Summary and Perspective 
 
In the chapter 2, I confirmed that 180EC stimulated regulation of FoxO1, FoxO3a, 
and myostatin activity. Furthermore, I demonstrated that AMPK activation was 
associated with reduced levels of the phosphorylated forms of FoxO1 and FoxO3a and 
stimulated myostatin levels. Thus, I conclude that AMPK activation plays an important 
role in the regulation of FoxO1, FoxO3a, and myostatin activity in case of induced 
muscle damage by 180EC. 
In chapter 3, I observed that 180EC induce nerve damage by confirming a 
damaged myelin sheath and reduction of NCV as well as muscle damage and protein 
degradation. Since I can’t conclude whether nerve damage by ECs induces AMPK 
activation and muscle protein degradation, I examined whether nerve damage induces 
AMPK activation and relate to levels of FoxO1 and FoxO3a and myostatin using a 
model of NCI in the chapter 4. 
As a result, meaning of AMPK activation, phosphorylated ACC was induced and 
the expression of myostatin was elevated with muscle atrophy. However, AMPK 
activation did not relate to levels of the phosphorylated forms of FoxO1 and FoxO3a. 
Thus, I conclude that AMPK is associated with the regulation of myostatin activity, but 
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phosphorylated states of FoxOs seem to be independent. 
In conclusion, 180EC induce not only muscle protein degradation but also nerve 
damage. Furthermore, AMPK activation and the expression of myostatin have an 
important role in case of nerve damage induced by 180EC. 
In the future, more studies will be necessary to determine whether inhibited 
AMPK activation and inhibited expression of myostatin support to prevention of muscle 
protein degradation when nerve is damaged. 
Consequently, blocking AMPK activation and the expression of myostatin may be 
effective for patients with muscle atrophy caused by nerve injury as well as muscle and 
nerve damage induced by severe ECs.  
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5-2 Figure  
 
 
 
 
 
 
 
 
 
 
 
Figure 5-1. Summary diagram 
The chapter 2 demonstrated that AMPK activation was associated with regulation of FoxO1, FoxO3a and 
myostatin activity after 180EC. 
In chapter 3, 180EC induced nerve damage as well as muscle damage and protein degradation.  
AMPK activation (phosphorylated ACC) and the expression of myostatin by NCI related to muscle 
atrophy in chapter 4. 
In conclusion, 180EC induce not only muscle protein degradation but also nerve damage.  
Also, AMPK activation and the expression of myostatin have an important role in case of nerve damage 
induced by 180EC. 
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AMPK: 5′-AMP-Activated Protein Kinase 
Akt: Protein kinase B, PKB 
BDNF: Brain-Derived Neurotrophic Factor 
CNS: Central Nervous System 
DOMS: Delayed-Onset Muscle Soreness 
EC: Eccentric Contraction 
ED1: Macrophage related protein 
FoxO: Forkhead box O 
MAFbx: Muscle-specific ubiquitin ligases muscle atrophy F-box, Atrogin-1 
mTOR: Mechanistic target of rapamycin  
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NT-4/5: Neurotrophin 4/5 
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